Applied Molecular Transport Financial Statements (AMTI)
|
|
Report date
|
|
|
31.12.2018 |
31.12.2019 |
19.03.2021 |
24.02.2022 |
09.03.2023 |
|
09.11.2023 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
Operating Income, bln rub |
|
|
-29.9 |
-28.3 |
-66.7 |
-100.8 |
-127.2 |
|
-76.5 |
EBITDA, bln rub |
? |
|
-29.2 |
-27.6 |
-66.7 |
-100.8 |
-127.2 |
|
-42.8 |
Net profit, bln rub |
? |
|
-29.9 |
-28.0 |
-64.5 |
-96.4 |
-125.4 |
|
-73.1 |
|
OCF, bln rub |
? |
|
-27.5 |
-27.0 |
-58.9 |
-82.6 |
-93.9 |
|
-60.0 |
CAPEX, bln rub |
? |
|
0.545 |
2.15 |
5.32 |
1.86 |
4.15 |
|
0.452 |
FCF, bln rub |
? |
|
-28.0 |
-29.1 |
-64.2 |
-84.5 |
-98.1 |
|
-60.5 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
|
|
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
29.9 |
28.3 |
66.7 |
100.8 |
127.2 |
|
59.7 |
Cost of production, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
R&D, bln rub |
|
|
27.9 |
24.3 |
53.9 |
71.4 |
89.8 |
|
30.2 |
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.579 |
|
Assets, bln rub |
|
|
23.2 |
38.5 |
140.2 |
214.0 |
107.4 |
|
20.0 |
Net Assets, bln rub |
? |
|
-44.1 |
-71.7 |
131.7 |
163.6 |
60.8 |
|
16.2 |
Debt, bln rub |
|
|
0.000 |
0.000 |
0.636 |
39.8 |
36.1 |
|
1.35 |
Cash, bln rub |
|
|
20.3 |
32.4 |
129.9 |
159.8 |
61.1 |
|
18.1 |
Net debt, bln rub |
|
|
-20.3 |
-32.4 |
-129.2 |
-120.0 |
-25.0 |
|
-16.8 |
|
Ordinary share price, rub |
|
|
|
|
30.8 |
14.0 |
0.420 |
|
0.140 |
Number of ordinary shares, mln |
|
|
17.6 |
21.4 |
22.9 |
37.6 |
38.8 |
|
39.8 |
|
Market cap, bln rub |
|
|
0 |
0 |
704 |
526 |
16 |
|
6 |
EV, bln rub |
? |
|
-20 |
-32 |
575 |
405 |
-9 |
|
-11 |
Book value, bln rub |
|
|
-44 |
-72 |
132 |
164 |
61 |
|
16 |
|
EPS, rub |
? |
|
-1.70 |
-1.31 |
-2.82 |
-2.56 |
-3.23 |
|
-1.84 |
FCF/share, rub |
|
|
-1.59 |
-1.36 |
-2.81 |
-2.25 |
-2.52 |
|
-1.52 |
BV/share, rub |
|
|
-2.51 |
-3.35 |
5.76 |
4.35 |
1.57 |
|
0.41 |
|
FCF yield, % |
? |
|
|
|
-9.12% |
-16.1% |
-601.1% |
|
-1 087% |
ROE, % |
? |
|
67.7% |
39.1% |
-49.0% |
-58.9% |
-206.2% |
|
-450.4% |
ROA, % |
? |
|
-128.5% |
-72.8% |
-46.0% |
-45.0% |
-116.7% |
|
-365.5% |
|
P/E |
? |
|
0.00 |
0.00 |
-10.9 |
-5.45 |
-0.13 |
|
-0.08 |
P/FCF |
|
|
0.00 |
0.00 |
-11.0 |
-6.22 |
-0.17 |
|
-0.09 |
P/BV |
? |
|
0.00 |
0.00 |
5.35 |
3.21 |
0.27 |
|
0.34 |
EV/EBITDA |
? |
|
0.69 |
1.17 |
-8.62 |
-4.02 |
0.07 |
|
0.26 |
Debt/EBITDA |
|
|
0.69 |
1.17 |
1.94 |
1.19 |
0.20 |
|
0.39 |
|
R&D/CAPEX, % |
|
|
5 125% |
1 129% |
1 015% |
3 833% |
2 163% |
|
6 689% |
|
Applied Molecular Transport shareholders |